Reading Room

Recommendations for Contraceptive Use

Previous PageNext PageTable Of Contents


Copper-Bearing Intrauterine Devices (IUDs)

Q.12. If a woman is at low risk of sexually transmitted diseases (STDs) based on history, mayintrauterine devices (IUDs) be inserted without any lab tests if there is no mucopurulent endocervical discharge or clinically apparent pelvic inflammatory disease (PID) or cervicitis?

Recommendations

Rationales

a) Yes, if the woman has no current risk factors for STDs (by history and on exam) and she has no apparent clinical signs or symptoms of infection (including normal bimanual exam).

b) If PID, mucopurulent endocervical discharge, cervicitis or clinically apparent vaginitis is present, do not insert IUD, but treat for infection. Consider other contraceptive methods, if an STD* is suspected.

* NOTE: Not all clinically-apparent vaginal infections are due to STDs.

a-b) Currently available lab tests may be impractical and often unaffordable (even in the developed world) to rule out endocervical colonization by infectious agents capable of ascending and causing PID. Most chlamydia tests are only 80 to 90% sensitive, tests for mycoplasma and ureaplasma are not routinely available, and cervical gram stain is less sensitive for gonorrhea. However, where gonorrhea culture and chlamydia tests are affordable, negative test results provide reassurance to corroborate the woman's history.

  1. Kramer D, Brown S. Sexually transmitted diseases and infertility. International Journal of Gynaecology and Obstetrics 1984;22:19-27.
  2. Bell TA, Grayston JT. Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Annals of Internal Medicine 1986;104:524-526.
  3. Nasello M, Callihan D, Menpus M, Steighigel R. A solid-phase enzyme immunoassay (gonozzyme®) test for direct detection of Neisseria gonorrhoeae antigen in urogenital specimens from patients at a sexually transmitted disease clinic. Sexually Transmitted Diseases 1985;(October-December):198-202.


Any part of Recommendations for Updating Selected Practices in Contraceptive Use may be reproduced or adapted to meet local needs without prior permission from the TG/CWG Secretariat, provided the TG/CWG is acknowledged and the material is made available free of charge or at cost.


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website

Top Of Page